AzTrials
AzTrials

Coronary Artery DiseaseNCT02144480

Efficacy of Early Short-term Training on Thrombogenesis in Patients Following Coronary Bypass Surgery

A study testing Intensive training and traditional training in people with Coronary Artery Disease, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Although the benefit of cardiac rehabilitation following coronary artery bypass graft (CABG) is well-established, it is underused. The current investigation will adopt an early, intensive, short-term and supervised aerobic training at moderate-intensity. Read more about this study

Who is it for?
Ages 20 to 90 years, men onlyHealthy volunteers can take part
Conditions the study is for
Coronary Artery Disease
What is being tested?
Intensive training and traditional training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
64 participants
Where
1 siteTaiwan
Study dates
Oct 2013to Jul 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 90 years
  • Men only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • CAD and scheduled to receive elective CABG. Male patients awaiting first-time elective CABG will be invited to participate in the study, and enrolled after giving written informed consent.

Who cannot join

  • musculoskeletal or neurological impairment precluding performance of cycling and walking assessment
  • receiving anticoagulation therapy
  • inability to complete questionnaires
  • a clinical status which requires emergent CABG
  • end-stage renal disease
  • peripheral arterial occlusive disease
Show all 22Show fewer
  • untreated life-threatening cardiac arrythmias
  • acute heart failure
  • uncontrolled hypertension
  • advanced atrioventricular block
  • acute myocarditis or pericarditis
  • acute systemic illness
  • intracardiac thrombus
  • progressive worsening of exercise tolerance or dyspnea at rest over previous 3-5 days
  • significant ischemia during low-intensity exercise (< 2 metabolic equivalent of tasks,< 50W)
  • uncontrolled diabetes
  • atrial fibrillation
  • atrial flutter
  • concurrent continuous or intermittent dobutamine therapy
  • decrease in systolic blood pressure with exercise
  • New York Heart Association (NYHA) class IV
  • supine resting heart rate > 100 bpm

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Chang Gung Memorial Hospital

    Linkuo, Taoyuan, 333

Other trials in Taiwan

About this study

Although the benefit of cardiac rehabilitation following coronary artery bypass graft (CABG) is well-established, it is underused. The current investigation will adopt an early, intensive, short-term and supervised aerobic training at moderate-intensity. The inclusion criteria are diagnosed coronary artery disease (CAD) and clinical indication for elective first-time CABG.

Regular physical exercise is associated with overall reduced risk of primary cardiac arrest. Previous study demonstrated that moderate-intensity exercise training reduced resting and strenuous exercise-induced activation of platelet and possibly coagulation. Our main research question is that whether the short-term CR program in the present investigation will ameliorate hemostatic imbalance at rest and platelet coagulation activation at maximal stress exercise.

Read more

This is designed to be a prospective randomized controlled study. Sixty men who are scheduled to receive elective CABG in Chang Gung Memorial Hospital at Linkuo will be enrolled in the study. They will be randomized into two groups: intensive training (IT) and usual rehabilitation (UR). Participants in the IT group will receive intensive aerobic training at moderate intensity after CABG. A submaximal exercise test will be performed for intensity prescription. They will receive two training sessions per day and at least 20 sessions in total. The CR group will receive usual CR program. After intervention, each participant will receive a maximal exercise test. Additionally, six-minute walk test, generic and disease-specific quality of life, will be collected before and after training. Additional 20 age-matched non-sedentary and healthy men without training will be recruited as control group.

Venous blood will be sampled three times (before and after rehabilitation and maximal stress test) for the assessment of platelet activation by flow cytometer and activity of coagulation factors. Mean platelet volume, and platelet activation markers (platelet-bound CD62P%G, CD63%G, CD40L%G) will be analyzed. Various coagulation and fibrinolysis factors will be quantified.

We hypothesized that this training program will ameliorate the prothrombotic state and attenuate platelet reactivity and coagulation induced by strenuous exercise in patients after CABG. Hopefully, this clinical investigation will establish an early short-term rehabilitation model following CABG and its efficacy for clinical use.

Read the detailed description

Introduction

The American College of Cardiology/American Heart Association guidelines suggested that cardiac rehabilitation (CR) should be offered to all eligible patients after coronary bypass surgery (CABG).[1] However, CR use in America is relatively low among Medicare beneficiaries despite convincing evidence of its benefits and recommendations for its use by professional organizations.[2] This neglect is as well evident in Taiwan. Traffic inconvenience and unavailability due to working hours are the common causes. There are ways to mend this situation. One of them is to develop an early, intensive and short-term CR program. The current investigation will adopt an early, intensive and supervised training for male patients following elective CABG due to old myocardial infarction and/or angina pectoris.

Meta-analyses of randomized controlled trials have consistently shown that participation in CR programs improves mortality and morbidity outcomes. It also benefits cardiopulmonary fitness, quality of life, lipid profile, etc.[3] Nonetheless, research regarding its effect on balance of thrombogenesis at rest or in response to vigorous exercise is either incomplete or controversial.

Previous studies found that acute physical exertion may trigger an acute coronary syndrome. The relative risk of cardiac events was 2-6 times higher during strenuous physical exertion (>6 METs) compared with during mild to moderate intensity activities in cardiac patients.[4] One of the possible explanations for this is that acute physical exertion may acutely change the hemostatic milieu in favor of increased coagulation and activation of platelet.[5] Available evidence suggests that strenuous exercise, in both healthy subjects and in various cardiovascular disease states, is associated with activation of platelets and blood coagulation, leading to a prothrombotic or hypercoagulable state.[6, 7] Aspirin is ineffective in attenuating enhanced platelet aggregation and activation induced by exercise.[8]

Regular physical exercise is associated with overall reduced risk of primary cardiac arrest.[4] D Wosornu et al. showed that a three-month aerobic training program (3 sessions per week) decreased resting fibrinogen concentration.[9] A meta-analysis showed that an exercise intervention over 2 weeks is associated with reduced inflammatory activity in patients with coronary artery disease (CAD). C-reactive protein and fibrinogen have provided the strongest evidence.[10] Platelet activation by strenuous exercise has been studied in 12 physically active and 12 sedentary individuals before and after a standardized treadmill exercise test. Among sedentary subjects, exercise caused an augmentation of the platelet activation and reactivity. In contrast, in physically active subjects exercise failed to induce alteration in platelet activation state.[11] Our previous study identified that moderate-intensity exercise training (60% maximal oxygen consumption for 30 min per day, 5 days/week for 8 weeks) reduced resting and strenuous exercise-induced platelet aggregation and platelet adhesion under shear flow in healthy men,[12] which were accompanied by decreased vWF binding to platelets and expression of P-selectin on platelets.[13] Accordingly, our main research question is that whether the short-term CR program in the current investigation ameliorates hemostatic imbalance at rest and platelet and coagulation activation at maximal stress exercise.

This is a prospective randomized controlled study. Sixty men who are scheduled to receive elective CABG in Chang Gung Memorial Hospital at Linkuo will be enrolled in the study. They will be randomized into two groups: intensive training (IT) and usual rehabilitation (UR). Participants in the IT group will receive education, reconditioning exercise and early intensive aerobic training at moderate intensity after CABG. A submaximal exercise test will be performed for prescription. They will receive two training sessions per day and at least 22 sessions in total. The CR group will receive usual CR program. After intervention, the participant will receive a maximal exercise test. In addition, six-minute walk test, generic and disease-specific quality of life will be collected before and after rehabilitation. Additional 20 age-matched, non-sedentary healthy participants without training will be recruited as control group.

Venous blood will be sampled three times (before and after rehabilitation and maximal stress test) for the assessment of platelet activation by flow cytometer and hemorheological profile by coagulation analyzer. Mean platelet volume, and platelet activation markers (platelet-bound CD62P%G, CD63%G, CD40L%G) will be analyzed. Various coagulation and fibrinolysis factors will be quantified including PT, aPTT, fibrinogen, thrombin time, FVIII:C, antithrombin, plasminogen, antiplasmin, anti-Xa and thrombin generation, D-Dimer, vWF etc.

We hypothesized that this training program will ameliorate the prothrombotic state and attenuate platelet reactivity and coagulation induced by strenuous exercise in patients after CABG. Hopefully, this clinical investigation will establish an early short-term rehabilitation model following CABG and its efficacy for clinical use.

Methodology

Participants A prospective study will be performed within the Cardiovascular Ward of Chang Gung Memorial Hospital, Linkuo. The inclusion criteria is diagnosed CAD and scheduled to receive elective CABG. Patients awaiting first-time elective CABG will be invited to participate in the study, and enrolled after giving written informed consent. Sixty patients will be enrolled. Exclusion criteria are musculoskeletal or neurological impairment precluding performance of cycling and walking assessment, atrial fibrillation, receiving anticoagulation therapy, inability to complete questionnaires, planned concomitant surgery, and a clinical status which requires emergent CABG. Additional 20 non-sedentary, age-matched healthy subjects without cardiovascular illness will be recruited as the control group. Non-sedentary life style is defined as walking more than 25 minutes in average per day according to the National Population Health Surveys of Canada. [14]

Randomization The patients will be randomized to two treatment groups (see Table 1 below) following assessment of study eligibility but prior to initial physiotherapy assessment. Randomization will be performed by means of random number generator based on their medical chart number. Thirty patients will be allocated to receive usual rehabilitation (UR); 30 to intensive training (IT).

Intervention protocol Physiotherapy interventions received by the two study groups are documented in Table 1. The IT group will receive physiotherapy twice daily with longer duration and higher intensity. After postoperative day5th, the training intensity will be prescribed at ventilatory anaerobic threshold (VAT) based on the submaximal exercise test in which the end point is supra-VAT. All physiotherapy interventions will be undertaken by one physiotherapist, specifically trained in the education and treatment methods used in the study.[15-17]

Supplemental oxygen will be used for all supervised/assisted walks if resting oxygen saturations is <92%. If patients are in sinus tachycardia (defined as >120 beats/min at rest) without hemodynamic compromise, exercise will be undertaken at a "comfortable" pace rather than at a "moderate" or "somewhat strong" level of perceived exertion. Patients will be counseled not to do walking training outside of physiotherapy sessions.

All patients will receive outcome assessment including cardiopulmonary exercise test, 6-minute-walk, quality of life, and hemorheological profile at basal and after strenuous exercise (Figure 1).

Being tested
Intensive training, traditional training
Keywords
coronary bypass surgery, rehabilitation, exercise training, platelet activation, cardiopulmonary fitness
Medical subject headings
Coronary Artery Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intensive trainingBehavioural

    The IT group will receive physiotherapy twice daily with longer duration and higher intensity

  • traditional trainingBehavioural

    usual care: conventional rehabilitation

Study groups in NCT02144480
Study groupRoleWhat they receive
Intensive trainingExperimentalintensive aerobic training in moderate intensity day5 postoperatively. 30 minutes per sessions, 2 sessions per day, 10 sessions per week. There will be 20 sessions in total.
Receives: Behavioral: Intensive training
traditional trainingSham comparatortraditional rehabilitation
Receives: Behavioral: traditional training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cardiopulmonary fitness

    before and after rehabilitation platelet activation before and after stress test

    Measured: 3 days to 4 weeks after coronary bypass

Secondary outcomes (1)
  1. platelet activity(composite measure)

    by flow cytometry

    Measured: 3 days to 4 weeks after coronary bypass

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2014 (estimated)
  2. Study startOct 2013
  3. Primary completionJul 2016
  4. Study completionJul 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02144480
Sponsor's protocol ID
102-3049A3
Status last verified
Aug 2016
First submitted
1 May 2014
Last updated
4 Nov 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol. 2010 Feb;7(2):77-86. doi: 10.1038/nrcardio.2009.228. Epub 2010 Jan 12.

    PubMed 20065951
  • Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003 Jul;19(1):71-82. doi: 10.1016/s1074-7613(03)00174-2.

    PubMed 12871640
  • Yang J, Zhang L, Yu C, Yang XF, Wang H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res. 2014 Jan 7;2(1):1. doi: 10.1186/2050-7771-2-1.

    PubMed 24398220
  • Shantsila E, Wrigley B, Tapp L, Apostolakis S, Montoro-Garcia S, Drayson MT, Lip GY. Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology. J Thromb Haemost. 2011 May;9(5):1056-66. doi: 10.1111/j.1538-7836.2011.04244.x.

    PubMed 21342432
  • Berg KE, Ljungcrantz I, Andersson L, Bryngelsson C, Hedblad B, Fredrikson GN, Nilsson J, Bjorkbacka H. Elevated CD14++CD16- monocytes predict cardiovascular events. Circ Cardiovasc Genet. 2012 Feb 1;5(1):122-31. doi: 10.1161/CIRCGENETICS.111.960385. Epub 2012 Jan 11.

    PubMed 22238190
  • Rogacev KS, Cremers B, Zawada AM, Seiler S, Binder N, Ege P, Grosse-Dunker G, Heisel I, Hornof F, Jeken J, Rebling NM, Ulrich C, Scheller B, Bohm M, Fliser D, Heine GH. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol. 2012 Oct 16;60(16):1512-20. doi: 10.1016/j.jacc.2012.07.019. Epub 2012 Sep 19.

    PubMed 22999728
  • Ozaki Y, Imanishi T, Taruya A, Aoki H, Masuno T, Shiono Y, Komukai K, Tanimoto T, Kitabata H, Akasaka T. Circulating CD14+CD16+ monocyte subsets as biomarkers of the severity of coronary artery disease in patients with stable angina pectoris. Circ J. 2012;76(10):2412-8. doi: 10.1253/circj.cj-12-0412. Epub 2012 Jun 29.

    PubMed 22785372
  • Amir O, Spivak I, Lavi I, Rahat MA. Changes in the monocytic subsets CD14(dim)CD16(+) and CD14(++)CD16(-) in chronic systolic heart failure patients. Mediators Inflamm. 2012;2012:616384. doi: 10.1155/2012/616384. Epub 2012 Nov 27.

    PubMed 23226928
  • Vandendries ER, Furie BC, Furie B. Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost. 2004 Sep;92(3):459-66. doi: 10.1160/TH04-05-0306.

    PubMed 15351841
  • Wrigley BJ, Shantsila E, Tapp LD, Lip GY. Increased formation of monocyte-platelet aggregates in ischemic heart failure. Circ Heart Fail. 2013 Jan;6(1):127-35. doi: 10.1161/CIRCHEARTFAILURE.112.968073. Epub 2012 Nov 14.

    PubMed 23152489
  • Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation. 2001 Sep 25;104(13):1533-7. doi: 10.1161/hc3801.095588.

    PubMed 11571248
  • Czepluch FS, Kuschicke H, Dellas C, Riggert J, Hasenfuss G, Schafer K. Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease. J Intern Med. 2014 Feb;275(2):144-54. doi: 10.1111/joim.12145. Epub 2013 Oct 30.

    PubMed 24118494
  • Williams MA, Ades PA, Hamm LF, Keteyian SJ, LaFontaine TP, Roitman JL, Squires RW. Clinical evidence for a health benefit from cardiac rehabilitation: an update. Am Heart J. 2006 Nov;152(5):835-41. doi: 10.1016/j.ahj.2006.05.015.

    PubMed 17070142
  • Hubal MJ, Chen TC, Thompson PD, Clarkson PM. Inflammatory gene changes associated with the repeated-bout effect. Am J Physiol Regul Integr Comp Physiol. 2008 May;294(5):R1628-37. doi: 10.1152/ajpregu.00853.2007. Epub 2008 Mar 19.

    PubMed 18353886
  • Mikkelsen UR, Couppe C, Karlsen A, Grosset JF, Schjerling P, Mackey AL, Klausen HH, Magnusson SP, Kjaer M. Life-long endurance exercise in humans: circulating levels of inflammatory markers and leg muscle size. Mech Ageing Dev. 2013 Nov-Dec;134(11-12):531-40. doi: 10.1016/j.mad.2013.11.004. Epub 2013 Nov 25.

    PubMed 24287006

Questions about this trial

What is this clinical trial studying?

A study testing Intensive training and traditional training in people with Coronary Artery Disease, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 22 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Nov 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cardiopulmonary fitness (time frame: 3 days to 4 weeks after coronary bypass). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02144480, which also lists 33 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in